These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25960269)

  • 1. Contact dermatitis caused by efinaconazole solution for treatment of onychomycosis.
    Hirohata A; Hanafusa T; Mabuchi-Kiyohara E; Ikegami R
    Contact Dermatitis; 2015 Sep; 73(3):190-2. PubMed ID: 25960269
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic contact dermatitis caused by efinaconazole: positive patch test reactions up to 0.1% pet.
    Oiso N; Tatebayashi M; Kawada A
    Contact Dermatitis; 2017 Jan; 76(1):53-54. PubMed ID: 27957750
    [No Abstract]   [Full Text] [Related]  

  • 3. Onychomadesis caused by efinaconazole.
    Yamaguchi Y; Hoshina D; Furuya K
    Contact Dermatitis; 2017 Jan; 76(1):57-58. PubMed ID: 27957751
    [No Abstract]   [Full Text] [Related]  

  • 4. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
    Lipner SR; Scher RK
    Expert Rev Clin Pharmacol; 2015; 8(6):719-31. PubMed ID: 26325488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efinaconazole 10% nail solution.
    Gupta AK; Simpson FC; Abramovits W
    Skinmed; 2013; 11(4):239-41. PubMed ID: 24053010
    [No Abstract]   [Full Text] [Related]  

  • 6. Efinaconazole topical solution (Jublia) for onychomycosis.
    Med Lett Drugs Ther; 2014 Sep; 56(1451):88-9. PubMed ID: 25211303
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and pharmacokinetics of efinaconazole 10% solution in healthy volunteers and patients with severe onychomycosis.
    Jarratt M; Siu WJ; Yamakawa E; Kodera N; Pillai R; Smith K
    J Drugs Dermatol; 2013 Sep; 12(9):1010-6. PubMed ID: 24002148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.
    Tschen EH; Bucko AD; Oizumi N; Kawabata H; Olin JT; Pillai R
    J Drugs Dermatol; 2013 Feb; 12(2):186-92. PubMed ID: 23377392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials.
    Gupta AK; Elewski BE; Sugarman JL; Ieda C; Kawabata H; Kang R; Pillai R; Olin JT; Watanabe S
    J Drugs Dermatol; 2014 Jul; 13(7):815-20. PubMed ID: 25007364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of gender as a clinically relevant outcome variable in the treatment of onychomycosis with efinaconazole topical solution 10.
    Rosen T
    Cutis; 2015 Sep; 96(3):197-201. PubMed ID: 26562270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes.
    Vlahovic TC; Joseph WS
    J Drugs Dermatol; 2014 Oct; 13(10):1186-90. PubMed ID: 25607552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric Patients.
    Eichenfield LF; Elewski B; Sugarman JL; Rosen T; Vlahovic TC; Gupta AK; Stein Gold L; Pillai R; Guenin E
    J Drugs Dermatol; 2020 Sep; 19(9):867-872. PubMed ID: 33026753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic contact dermatitis caused by amorolfine in a nail lacquer.
    Romita P; Stingeni L; Hansel K; De Prezzo S; Ambrogio F; Bonamonte D; Foti C
    Contact Dermatitis; 2019 Nov; 81(5):407-408. PubMed ID: 31314139
    [No Abstract]   [Full Text] [Related]  

  • 14. Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early.
    Rich P
    J Drugs Dermatol; 2015 Jan; 14(1):58-62. PubMed ID: 25607909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efinaconazole (Jublia) for the treatment of onychomycosis.
    Gupta AK; Simpson FC
    Expert Rev Anti Infect Ther; 2014 Jul; 12(7):743-52. PubMed ID: 24850511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on Efinaconazole 10% Topical Solution for the Treatment of Onychomycosis.
    Gupta AK; Studholme C
    Skin Therapy Lett; 2016 Nov; 21(6):7-11. PubMed ID: 27825175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic contact dermatitis caused by undecylenic acid in an antifungal nail solution.
    Ochando-Ibernón G; Schneller-Pavelescu L; Vergara de Caso EF; Silvestre-Salvador JF
    Contact Dermatitis; 2019 May; 80(5):313-314. PubMed ID: 30537336
    [No Abstract]   [Full Text] [Related]  

  • 18. Efinaconazole: a new topical treatment for onychomycosis.
    Gupta AK; Simpson FC
    Skin Therapy Lett; 2014; 19(1):1-4. PubMed ID: 24570290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic contact dermatitis from undecylenic acid in a commercial antifungal nail solution.
    Anguita JL; Escutia B; Marí JI; Rodríguez M; De La Cuadra J; Aliaga A
    Contact Dermatitis; 2002 Feb; 46(2):109. PubMed ID: 11918606
    [No Abstract]   [Full Text] [Related]  

  • 20. Efinaconazole in Onychomycosis.
    Gupta AK; Talukder M
    Am J Clin Dermatol; 2022 Mar; 23(2):207-218. PubMed ID: 34902110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.